Reporter | Business

Christopher Snowbeck covers health insurers, including Minnetonka-based UnitedHealth Group, and the business of running hospitals and clinics. 

Since 1994, Snowbeck has covered health care stories at four newspapers including the St. Paul Pioneer Press, the Pittsburgh Post-Gazette and the Daily Progress of Charlottesville, Va. He lives in St. Paul with his wife, two daughters and two cats. He graduated from Carleton College as a history major with a concentration in medieval studies. He serves on the board of directors for the Minnesota Society of Professional Journalists. He's also a runner.

UnitedHealth Group opens 'pop-up' infusion center for COVID-19 patients

"Monoclonal antibodies" given in Minnetonka to help avoid hospitalization.

Minnesota's COVID cases are down, but for how long?

Despite the decline, there's considerable uncertainty about whether it can be sustained, particularly as more contagious versions spread.

Allina, Optum plan to build surgery center in Brooklyn Park

Joint venture that was formed in 2019 plans to open or acquire about a dozen surgery centers in five years.

Coronavirus variant spreading in Minnesota

Officials fear a second wave of more contagious virus strain could emerge.

Minnesota reports 884 new COVID-19 cases, 11 more deaths

The count for people with at least one vaccine dose now exceeds 742,000.

Minnesota hits 1 million mark with COVID-19 vaccine doses

The state postponed appointments at some community vaccination locations after severe winter weather in other parts of the country delayed at least part of this week's COVID-19 vaccine doses.

Google will open first office in Minnesota, and it's not in the Twin Cities

Rochester location fits with the tech giant's Mayo Clinic collaboration.

North Memorial Health Hospital nurse named to Biden COVID task force

Mary Turner, president of the Minnesota Nurses Association, will join group focused on health inequities.

New UnitedHealth CEO Witty could see $18.8 million in pay for 2021

After abrupt departure, former CEO will see salary and incentive pay for two years.

U studies antibodies for short-term immunity vs. COVID-19

Antibodies show promise in virus prevention efforts, not just treatment.